TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · IEX Real-Time Price · USD
143.08
+1.06 (0.75%)
At close: Jun 17, 2024, 4:00 PM
143.38
+0.31 (0.21%)
After-hours: Jun 17, 2024, 7:58 PM EDT
TransMedics Group Revenue
TransMedics Group had revenue of $296.92M in the twelve months ending March 31, 2024, with 149.23% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $96.85M with 133.07% year-over-year growth. In the year 2023, TransMedics Group had annual revenue of $241.62M with 158.53% growth.
Revenue (ttm)
$296.92M
Revenue Growth
+149.23%
P/S Ratio
15.87
Revenue / Employee
$508,423
Employees
584
Market Cap
4.71B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 241.62M | 148.16M | 158.53% |
Dec 31, 2022 | 93.46M | 63.20M | 208.83% |
Dec 31, 2021 | 30.26M | 4.62M | 18.03% |
Dec 31, 2020 | 25.64M | 2.04M | 8.62% |
Dec 28, 2019 | 23.60M | 10.59M | 81.33% |
Dec 29, 2018 | 13.02M | 5.33M | 69.38% |
Dec 30, 2017 | 7.69M | 1.48M | 23.77% |
Dec 31, 2016 | 6.21M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Select Medical Holdings | 6.79B |
Option Care Health | 4.43B |
PACS Group | 3.34B |
RadNet | 1.66B |
Haemonetics | 1.31B |
Merit Medical Systems | 1.28B |
Stevanato Group | 1.18B |
Inspire Medical Systems | 660.91M |
TMDX News
- 6 days ago - Top 4 Health Care Stocks That May Keep You Up At Night This Month - Benzinga
- 4 weeks ago - TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 6 weeks ago - TransMedics Reports First Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024 - PRNewsWire
- 3 months ago - TMDX INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation - TMDX - PRNewsWire
- 3 months ago - TransMedics to Present at Upcoming March Investor Conferences - PRNewsWire
- 4 months ago - ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX - Business Wire
- 4 months ago - TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results - PRNewsWire